相关实验视频
Updated: Jul 6, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
检查点抑制性心肌炎,先前有免疫抑制和对顺序性 antracycline 治疗的耐受性
Nicholas Kiran Singh Grewal1, Jennifer Maning2, Leo I Gordon3
1Medicine, Northwestern Medicine, Chicago, Illinois, USA.
这项案例研究强调了用尼沃卢马布治疗淋巴瘤患者的免疫检查点抑制剂 (ICI) 心肌炎,导致心力衰竭. 它还检查了ICI诱导心肌炎后随后的环素治疗的安全性.
科学领域:
- 心脏瘤学 - 心脏瘤学
- 免疫学 免疫学 免疫学
- 心脏病学 心脏病学
背景情况:
- 像尼沃卢马布这样的免疫检查点抑制剂 (ICI) 在癌症治疗中至关重要.
- 心脏并发症,包括心肌炎,是ICI的潜在副作用.
- 在ICI诱导心脏毒性后继续化疗的安全性尚未得到充分证实.
更多相关视频
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
相关概念视频
Tumor Immunotherapy
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Heart Failure Drugs: Inotropic Agents
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Cell-mediated Immune Responses